Thomas Anderson - Net Worth and Insider Trading
Thomas Anderson Net Worth
The estimated net worth of Thomas Anderson is at least $167,800 dollars as of 2024-12-28. Thomas Anderson is the Director of Zevra Therapeutics Inc and owns about 20,000 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $167,800. Thomas Anderson is also the See Remarks of Sage Therapeutics Inc and owns about 0 shares of Sage Therapeutics Inc (SAGE) stock worth over $0. Details can be seen in Thomas Anderson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Anderson has not made any transactions after 2024-07-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas Anderson
Thomas Anderson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Anderson owns 2 companies in total, including Sage Therapeutics Inc (SAGE) , and Zevra Therapeutics Inc (ZVRA) .
Click here to see the complete history of Thomas Anderson’s form 4 insider trades.
Insider Ownership Summary of Thomas Anderson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SAGE | Sage Therapeutics Inc | 2016-11-15 | See Remarks |
| ZVRA | Zevra Therapeutics Inc | 2024-07-16 | director |
Thomas Anderson Latest Holdings Summary
Thomas Anderson currently owns a total of 2 stocks. Among these stocks, Thomas Anderson owns 20,000 shares of Zevra Therapeutics Inc (ZVRA) as of July 16, 2024, with a value of $167,800 and a weighting of 100%. Thomas Anderson also owns 0 shares of Sage Therapeutics Inc (SAGE) as of November 15, 2016, with a value of $0 and a weighting of 0%.
Latest Holdings of Thomas Anderson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2024-07-16 | 20,000 | 8.39 | 167,800 |
| SAGE | Sage Therapeutics Inc | 2016-11-15 | 0 | 5.54 | 0 |
Holding Weightings of Thomas Anderson
Thomas Anderson Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Anderson has made a total of 2 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 10,000 shares on July 16, 2024, which cost Thomas Anderson around $68,100.
According to the SEC Form 4 filings, Thomas Anderson has made a total of 0 transactions in Sage Therapeutics Inc (SAGE) over the past 5 years. The most-recent trade in Sage Therapeutics Inc is the sale of 10,000 shares on November 15, 2016, which brought Thomas Anderson around $550,000.
Insider Trading History of Thomas Anderson
- 1
Thomas Anderson Trading Performance
GuruFocus tracks the stock performance after each of Thomas Anderson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas Anderson is 14.38%. GuruFocus also compares Thomas Anderson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas Anderson within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas Anderson's insider trading performs compared to the benchmark.
Performance of Thomas Anderson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.54 | | | | | |
| Relative Return to S&P 500(%) | 6.29 | | | | | |
Thomas Anderson Ownership Network
Thomas Anderson Owned Company Details
What does Sage Therapeutics Inc do?
Who are the key executives at Sage Therapeutics Inc?
Thomas Anderson is the See Remarks of Sage Therapeutics Inc. Other key executives at Sage Therapeutics Inc include director & See Remarks Jeffrey M Jonas , Chief Medical Officer Laura Gault , and Chief Commercial Officer Christopher Benecchi .
Sage Therapeutics Inc (SAGE) Insider Trades Summary
Over the past 18 months, Thomas Anderson made no insider transaction in Sage Therapeutics Inc (SAGE). Other recent insider transactions involving Sage Therapeutics Inc (SAGE) include a net purchase of 2,000 shares made by Elizabeth Barrett ,
In summary, during the past 3 months, insiders sold 0 shares of Sage Therapeutics Inc (SAGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sage Therapeutics Inc (SAGE) were sold and 2,000 shares were bought by its insiders, resulting in a net purchase of 2,000 shares.
Sage Therapeutics Inc (SAGE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sage Therapeutics Inc Insider Transactions
Thomas Anderson Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Anderson. You might contact Thomas Anderson via mailing address: 215 First Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
